Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,108.40
(
-0.41%
)
US TECH 100
26,203.20
(
0.00%
)
Dow Jones
49,310.32
(
-0.36%
)
Brent Oil
100.76
(
-0.44%
)
Bitcoin
77,664.10
(
-0.78%
)
News Focus
News Focus
Post# of 257442
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

masterlongevity

Send PM Follow Ignore
Followers 24
Posts 2597
Boards Moderated 0
Alias Born 01/07/2004

masterlongevity

Re: masterlongevity post# 96026

Wednesday, 05/19/2010 3:12:22 PM

Wednesday, May 19, 2010 3:12:22 PM

Post# of 257442
Lilly AD

just to note, if this product gets approval (which should be in 2013), it will have been a 9 yr gap since any new AD therapy has been approved.

AD is now the holy grail for pharmaceutial companies due to the size of the market and the dearth of treament options
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today